” Even though the Ricaurte Tale was unfolding, MAPS lastly gained FDA signal-off on the protocol for human trials of MDMA as being a remedy for PTSD, but only following it bought a $one million insurance plan policy to indemnify the overview board.Potentially it can be well worth turning the concern all over and inquiring what MDMA tells us about